MamaMancini’s Holdings, Inc. — Form 10-K Summary
Reporting period: Fiscal year ended January 31, 2023. Although the request refers to 2022 Q4, this filing reports annual results; it does not provide clear standalone fourth-quarter financial results. The company manufactures and sells refrigerated prepared foods. Fiscal 2023 includes a full year of T&L Creative Salads and Olive Branch operations, acquired December 29, 2021.
Financial performance and liquidity
| Metric | FY ended Jan. 31, 2023 | FY ended Jan. 31, 2022 |
|---|---|---|
| Net sales | $93.19 million | $47.08 million |
| Gross profit / margin | $19.42 million / 20.8% | $11.85 million / 25.2% |
| Operating income / margin | $2.82 million / 3.0% | $82,767 / 0.2% |
| Net income (loss) | $2.30 million | $(251,926) |
| Net income (loss) per share, basic and diluted | $0.06 | $(0.01) |
| Cash from operating activities | $5.51 million | $909,841 |
| Cash used in investing activities | $1.09 million | $11.27 million |
| Cash used in financing activities | $888,037 | Cash provided: $8.02 million |
Sales increased approximately 98%, reflecting strong sales and product additions at existing customers as well as the acquired businesses’ full-year contribution. Management cited cost normalization and manufacturing efficiencies, but gross margin fell about 4.4 percentage points. Operating expenses rose 41% in dollars, while declining from 25% to 18% of sales.
At January 31, 2023, cash was $4.38 million, current assets $15.67 million, current liabilities $11.88 million, and working capital $3.80 million. The company reported total liabilities of $22.07 million. Borrowings included a term loan with a net carrying value of approximately $6.15 million, a $890,000 revolving credit balance, and a $2.25 million related-party acquisition note. The term loan and revolver bear variable interest rates; the revolving facility has a $5.5 million limit and matures June 30, 2024, and the term loan matures January 17, 2027. The company reported compliance with bank covenants at year-end. Cash and cash equivalents increased from $851,000 a year earlier.
Operating cash flow improved substantially. Investing outflows included $593,000 for equipment and $500,000 cash invested in Chef Inspirational Foods (CIF). Financing activity included $1.365 million raised through Series B preferred stock, offset by loan and finance-lease repayments, preferred dividends, and offering costs.
Material changes and unusual items
- The T&L and Olive Branch acquisitions materially expanded the business and contributed a full year of sales in FY2023, compared with only the post-acquisition period in FY2022.
- Gross profit increased, but gross margin declined. Operating costs rose, including payroll and related expenses (approximately $2.4 million), commissions and freight (approximately $650,000 each), insurance (approximately $375,000), and a $233,000 doubtful-account provision.
- Interest expense rose to approximately $634,000 from $73,000, principally reflecting acquisition financing.
- In June 2022, the company acquired a 24% CIF interest for $1.2 million, comprising $500,000 cash and $700,000 in common stock. It also held an option to acquire the remaining 76% for an additional $3.8 million, exercisable within one year of June 28, 2022.
- The company raised $1.365 million through Series B preferred shares. These shares carry cumulative 8% dividends and are convertible into common stock, creating potential dilution.
- CEO Adam Michaels and CFO Anthony Gruber joined in 2022. Management reported that it remediated a previously identified material weakness in internal controls during fiscal Q4; management concluded internal control over financial reporting was effective as of January 31, 2023.
Outlook, risks and contingencies
Management said expected revenue growth and expense control lead it to believe cash resources should meet requirements through April 26, 2024, based on current and projected operations. It also cautioned that additional funding may be needed to finance growth and that financing may not be available on acceptable terms. No specific revenue or earnings guidance was provided.
- Customer concentration: Two customers accounted for approximately 37% of FY2023 gross revenue, versus three customers accounting for approximately 58% in FY2022. Three customers represented 46% of year-end gross receivables.
- Costs and demand: The company identifies food-price volatility, inflation, interest rates, consumer demand, competition, and broader economic conditions as risks to margins and results.
- Funding and banking: Variable-rate debt creates interest-rate exposure. The filing discusses potential financial-institution liquidity disruptions and possible impacts on access to deposits and credit.
- Other exposures: The company depends on key personnel and must comply with food-safety, labeling, and other regulatory requirements. Approximately $3.5 million of cash exceeded federally insured limits at year-end.
- Related parties: The Farmingdale production facility is leased from an entity owned by T&L’s president and related individuals; the company also owes the acquisition note to the sellers.
- The company reported no material litigation and no goodwill impairment. The independent auditor issued an unqualified opinion on the financial statements and reported no critical audit matters.
Important facts for investors to verify
- How much of the 98% sales increase came from acquired operations versus organic growth, and whether margins can recover from the FY2023 decline.
- Customer concentration, continued order activity, receivable collections, and the adequacy of the increased doubtful-account allowance.
- Debt repayment capacity, variable-rate interest costs, covenant terms, and liquidity after the revolving credit facility matures.
- Whether the CIF option was exercised, and the cash, stock, and funding implications of any further acquisition.
- Potential dilution and dividend obligations from Series B preferred stock, options, and restricted stock units.
- The cash-flow statement reports FY2023 operating cash flow of $5,509,036, while the MD&A states $5,509,162; verify the correct figure against the filed financial statements.